Literature DB >> 25748898

First US biosimilar edges towards market.

Melanie Senior.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25748898     DOI： 10.1038/nbt0315-222

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Building a wall against biosimilars.

Authors: 
Journal:  Nat Biotechnol       Date:  2013-04       Impact factor: 54.908

2.  Biosimilars battle rages on, Amgen fights both sides.

Authors:  Melanie Senior
Journal:  Nat Biotechnol       Date:  2013-04       Impact factor: 54.908
  2 in total
  2 in total

1.  First US biosimilar launch.

Authors: 
Journal:  Nat Biotechnol       Date:  2015-10       Impact factor: 54.908

2.  Celltrion's infliximab copy shows path to biosimilars in US.

Authors:  Eva von Schaper
Journal:  Nat Biotechnol       Date:  2016-05-06       Impact factor: 54.908
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.